Less than 1 min.Read

Correlia Biosystems: Raises $7M in Series A Funding

December 6, 2020

Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
NeoTribe Ventures joins Correlia’s board of directors as part of the financing
The company also intends to use the funds for the commercial launch of its immunoassay platform
This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics